D And O Pharmachem (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 30 Year, 5 Months
- Last Filing with ROC 31 Mar 2018
- Satisfied Charges ₹ 1.31 M
- Revenue Growth %
- Profit Growth -25.25%
- Ebitda -27.06%
- Net Worth -40.39%
- Total Assets -41.68%
About D And O Pharmachem (India)
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24110MH1994PLC081359
- Company No.
081359
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
22 Sep 1994
- Date of AGM
29 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at D And O Pharmachem (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandrashekhar Nadkarni  | Managing Director | 22-Sep-1994 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shibani Nadkarni | Director | 22-Sep-1994 | Current |
| Rohit Gulgule | Director | 26-Feb-2002 | Current |
Financial Performance of D And O Pharmachem (India).
D And O Pharmachem (India) Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 25.25% decrease in profit. The company's net worth observed a substantial decline by a decrease of 40.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of D And O Pharmachem (India)?
In 2017, D And O Pharmachem (India) had a promoter holding of 99.60% and a public holding of 0.40%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Thinq Pharma-Cro LimitedShibani Nadkarni, Rohit Gulgule and 1 more are mutual person
Charges (Loans)
₹0
₹1.31 M
Charges Breakdown by Lending Institutions
- The Saraswat Co-Op. Bank Ltd. : 0.13 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Apr 2000 | The Saraswat Co-Op. Bank Ltd. | ₹0.27 M | Satisfied |
| 07 Apr 2000 | The Saraswat Co-Op. Bank Ltd. | ₹0.91 M | Satisfied |
| 20 Mar 1998 | The Saraswat Co-Op. Bank Ltd. | ₹0.13 M | Satisfied |
How Many Employees Work at D And O Pharmachem (India)?
Unlock and access historical data on people associated with D And O Pharmachem (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of D And O Pharmachem (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped D And O Pharmachem (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.